Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Liabilities and Shareholders Equity (2020 - 2025)

P3 Health Partners (PIII) has disclosed Liabilities and Shareholders Equity for 6 consecutive years, with $683.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Liabilities and Shareholders Equity fell 17.97% year-over-year to $683.6 million, compared with a TTM value of $3.0 billion through Sep 2025, down 14.27%, and an annual FY2024 reading of $783.4 million, changed N/A over the prior year.
  • Liabilities and Shareholders Equity was $683.6 million for Q3 2025 at P3 Health Partners, down from $731.6 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $2.4 billion in Q1 2022 and bottomed at $6.5 million in Q1 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $876.8 million, with a median of $844.6 million recorded in 2024.
  • The sharpest move saw Liabilities and Shareholders Equity surged 35973.12% in 2022, then tumbled 63.19% in 2023.
  • Year by year, Liabilities and Shareholders Equity stood at $316.6 million in 2021, then soared by 176.85% to $876.6 million in 2022, then rose by 2.32% to $896.9 million in 2023, then fell by 12.65% to $783.4 million in 2024, then dropped by 12.75% to $683.6 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for PIII at $683.6 million in Q3 2025, $731.6 million in Q2 2025, and $783.9 million in Q1 2025.